These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6146518)

  • 1. Effect of Ala-2-D-Trp-8-D-Cys-14-somatostatin on the arginine induced release of insulin, GH and glucagon in normal men.
    Gonzalez-Barcena D; Mendoza F; Medina R; Coy DH; Murphy WA; Schally AV
    Endocr Res; 1984; 10(1):39-48. PubMed ID: 6146518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of highly potent octapeptide analogs of somatostatin on growth hormone, insulin and glucagon release.
    Karashima T; Cai RZ; Schally AV
    Life Sci; 1987 Aug; 41(8):1011-9. PubMed ID: 2886886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on growth hormone secretion. VII. Effects of somatostatin on plasma GH, insulin, and glucagon in sheep.
    Bryce D; Yeh M; Funderburk C; Todd H; Hertelendy F
    Diabetes; 1975 Sep; 24(9):842-50. PubMed ID: 169176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatostatin-28 is longer acting and more selective than somatostatin-14 on pituitary and pancreatic hormone release.
    Tannenbaum GS; Ling N; Brazeau P
    Endocrinology; 1982 Jul; 111(1):101-7. PubMed ID: 6123428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective effect of some somatostatin analogs on glucagon as opposed to insulin release in rats in vivo.
    Lins PE; Efendić S; Meyers CA; Coy DH; Schally A; Luft R
    Metabolism; 1980 Aug; 29(8):728-31. PubMed ID: 6105610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissociated effects of somatostatin analogs on arginine-induced insulin, glucagon and growth hormone release in acromegalic patients.
    Wajchenberg BL; Cesar FP; Leme CE; Borghi VC; Souza VC; Souza IT; Neto DG; Germek OA; Coy DH; Comaru-Schally AM
    Horm Metab Res; 1983 Oct; 15(10):471-4. PubMed ID: 6139329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of growth hormone and glucagon release by Phe-4-somatostatin in patients with acromegaly.
    Charro AL; Cabranes JA; Lafuente A; Diaz-Salgado C; Cordero M; Almoguera I; Comaru-Schally AM; Meyers CA; Coy DH; Schally AV
    Res Commun Chem Pathol Pharmacol; 1984 Sep; 45(3):432-44. PubMed ID: 6150529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superactive somatostatin analog decreases plasma glucose and glucagon levels in diabetic rats.
    Karashima T; Schally AV
    Peptides; 1988; 9(3):561-5. PubMed ID: 2901737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of somatostatin and a glucagon-specific analog on glucose homeostasis during arginine infusion.
    Lien EL
    Metabolism; 1978 Sep; 27(9):1095-100. PubMed ID: 682972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective inhibition of sleep related growth hormone release by Phe-4-somatostatin.
    Cabranes JA; Vela A; Timoneda F; Meyers CA; Coy DH; Schally AV; Charro AL
    Res Commun Chem Pathol Pharmacol; 1984 Sep; 45(3):421-31. PubMed ID: 6150528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic effects of graded glucagon infusions in man: inhibition of glucagon, insulin, and somatostatin response to arginine.
    Pontiroli AE; Perfetti MG; Andreotti AC; Fattor B; Monti LD; Pozza G
    Metabolism; 1993 Oct; 42(10):1242-8. PubMed ID: 8105365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of specific and non-specific somatostatin analogs.
    Nakano T; Harano Y; Emura J; Kimura T; Sakakibara S; Shigeta Y
    Horm Metab Res; 1986 Feb; 18(2):98-102. PubMed ID: 2870971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of prosomatostatin on growth hormone and prolactin response to arginine in man. Comparison with somatostatin.
    Rodriguez-Arnao MD; Gomez-Pan A; Rainbow SJ; Woodhead S; Comaru-Schally AM; Schally AV; Meyers CA; Coy DH; Hall R
    Lancet; 1981 Feb; 1(8216):353-6. PubMed ID: 6109991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of a long acting glucagon selective somatostatin analogue on plasma glucose, insulin and glucagon levels in the anaesthetized rat during arginine infusion.
    Lien E; Sarantakis D
    Diabetologia; 1979 Jul; 17(1):59-64. PubMed ID: 467854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the somatostatin analog D-Trp8,D-Cys14 on glucose insulin, pancreatic glucagon and growth hormone plasma levels in acromegalics and mild diabetics.
    Trovati M; Massara F; Camanni F; Molinatti GM; Lorenzati R; Pagano GF
    J Endocrinol Invest; 1980; 3(2):189-92. PubMed ID: 6104680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatostatin-28 and somatostatin-14 suppression of arginine-, insulin-, and TRH-stimulated GH and PRL secretion in man.
    Millar RP; Klaff LJ; Barron JL; Levitt NS; Ling N
    Clin Endocrinol (Oxf); 1983 Mar; 18(3):277-85. PubMed ID: 6134596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective inhibitory effect of the analog D5-F-TrP8-D-Cys14 somatostatin on the arginine induced release of insulin, growth hormone and glucagon, in normal human beings.
    González-Bárcena D; Mendoza F; Graef A; Medina R; Comaru-Schally AM; Schally AV
    Arch Invest Med (Mex); 1985; 16 Suppl 3():105-14. PubMed ID: 2878649
    [No Abstract]   [Full Text] [Related]  

  • 18. Biological activity of somatostatin and somatostatin analogs on inhibtion of arginine-induced insulin and glucagon release in the rat.
    Brown M; Rivier J; Vale W
    Endocrinology; 1976 Feb; 98(2):336-43. PubMed ID: 813991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The somatostatin analog SMS 201-995 induces long-acting inhibition of growth hormone secretion without rebound hypersecretion in acromegalic patients.
    Lamberts SW; Oosterom R; Neufeld M; del Pozo E
    J Clin Endocrinol Metab; 1985 Jun; 60(6):1161-5. PubMed ID: 2860119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of pancreatic hormone secretion by somatostatin-28 and somatostatin-14 in man.
    Klaff LJ; Barron JL; Levitt NS; Ling N; Millar RP
    Acta Endocrinol (Copenh); 1983 Sep; 104(1):91-5. PubMed ID: 6137927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.